Business Description
Entera Bio is an Israel-based company focused on turning injectable hormone and protein treatments into pills that patients can swallow. The company has several drugs in clinical testing, targeting conditions such as osteoporosis, obesity, and rare hormonal disorders. Its most advanced candidate is an oral version of teriparatide, a drug commonly used to treat bone loss, which has already completed a mid-stage clinical trial. Entera also works with partner companies to advance additional treatments through early-stage research and testing.
